E: investor@claritypharmaceuticals.com W: www.claritypharmaceuticals.com ACN: 143 005 341 T: +61 (0)2 9209 4037 CLARITY PHARMACEUTICALS LIMITED ASX MEDIA RELEASE 27 August 2026 Appendix 4E Preliminary Final Report – 30 June 2026 Clarity Pharmaceuticals Ltd (ASX:...